Can a psychedelic compound help veterans and first responders with PTSD and alcohol use disorder?

NCT ID NCT06853912

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This phase 2 trial is investigating whether psilocybin, the active compound in magic mushrooms, combined with psychological support, is safe and suitable for military veterans and first responders who have both alcohol use disorder (AUD) and posttraumatic stress disorder (PTSD). About 40 participants will receive either psilocybin or a placebo during a guided session, with an open-label extension for those who received placebo. The study focuses on safety, including monitoring for adverse events and suicidal thoughts, and also explores participants' subjective experiences.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
psilocybin (25 mg) combined with psychological support
What this could lead to
If successful, this could point toward a new treatment approach for veterans and first responders struggling with both alcohol use disorder and PTSD.
What could go wrong
This is an early-phase trial with only 40 participants, so results may not apply broadly. Psilocybin can cause intense psychological effects, and safety monitoring is a key focus.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER (AUD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Washington Center for Novel Therapeutics in Addiction Psychiatry

    Seattle, Washington, 98195, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.